Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
GSK Rises
GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
GSK Plc shares surged after the UK pharma company agreed to pay as much as $2.2 billion to resolve about 80,000 US court cases alleging that its old reflux medication Zantac was contaminated with a suspected carcinogen.
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 billion
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on Wednesday.
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
FiercePharma
3d
GSK will pony up $2.2B to resolve 80K Zantac cases
The agreement frees the British pharma giant from litigating 93% of the state court cases it faced in the U.S.
3d
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2 bln
GSK has agreed to pay up to $2.2 billion to settle most lawsuits in U.S. state courts claiming that a discontinued version of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Sued by former assistant
How to help Milton victims
Soldier sentenced to 14 yrs
Dems shut down AZ office
Oklahoma mass shooting
Free gas for FL residents
Israel orders evacuation
Toxic mushrooms poison 11
Says systems were breached
Turtle smuggling guilty plea
Releases medical report
Tour guide killed in mine
Holds rally in California
Wins Xfinity Series race
FAA OKs Starship 5 launch
Admonishes Black men
Drug for hemophilia approved
To cut workforce by 10%
Expands sanctions on Iran
FTX exec heads to prison
Dodgers advance to NLCS
Files suit against Virginia
Airstrikes hit ISIS camps
S&P 500, Dow hit records
Adds 8 new destinations
Gets 2 years for role in riot
CA rejects SpaceX plan
Gets Walk of Fame star
To close 444 stores
Feedback